Novocure Ltd (NVCR)

90.90
+0.85(+0.94%)
After Hours
90.60
-0.30(-0.33%)
- Real-time Data
  • Volume:
    542,608
  • Day's Range:
    88.72 - 91.69
  • 52 wk Range:
    56.39 - 120.03

NVCR Overview

Prev. Close
90.05
Day's Range
88.72-91.69
Revenue
542.63M
Open
90.04
52 wk Range
56.39-120.03
EPS
-0.783
Volume
542,608
Market Cap
9.54B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
921,546
P/E Ratio
-115.50
Beta
0.764
1-Year Change
44.42%
Shares Outstanding
104,950,082
Next Earnings Date
Feb 23, 2023
What is your sentiment on Novocure Ltd?
or
Market is currently closed. Voting is open during market hours.

Novocure Ltd Analysis

Novocure Ltd Company Profile

Novocure Ltd Company Profile

NovoCure Limited is an oncology company. The Company is principally engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. TTFields therapy is a treatment that uses electric fields tuned to specific frequencies to disrupt cancer cell division. TTFields therapy is delivered through a portable medical device. Optune is approved by the United States Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) together with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Optune Lua is approved by the FDA for the pathway for the treatment of malignant pleural mesothelioma (MPM) together with standard chemotherapies. It markets its products to United States, European Union, Germany, Japan and certain other countries.

Read More

Analyst Price Target

Average104.43 (+14.88% Upside)
High200.00
Low42.00
Price90.90
No. of Analysts7
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral
  • Quiet forum? suprised no one bought their chance of approval of their tumor medicine. its the first stock i ordered when they applied for it.
    1
    • Just bought some
      0
  • I am done with this stock. I am selling all my shares and calls tomorrow and invest in bitcoins instead.
    6
    • wish this drop like the related scam dogecoin.
      2
      • just drop to $130 already.
        1
        • dropping back to $130.
          0
          • going up today ?
            0
            • short blindly when it reach 70% up around 220 -230 and wait 2 days only it will be in the range of 200 - 180
              0
              • Is it already too late to buy now?
                0
                • Anybody guess how it will close today? Cheers.
                  0
                  • ?????
                    0
                    • phase 3 on tumor removal treatments
                      0
                    • buy on 175 ?
                      0
                    • was the results good?
                      0